TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway.
Zhou Q, You Y, Zhao Y, Xiao S, Song Z, Huang C, Qian J, Lu W, Tong H, Zhang Y, Wang Z, Li W, Zhang C, Guo X, Luo R, Hou Y, Cui J, Lu L, Zhou Y.
Zhou Q, et al. Among authors: zhou y.
Cell Oncol (Dordr). 2024 Nov 29. doi: 10.1007/s13402-024-01008-7. Online ahead of print.
Cell Oncol (Dordr). 2024.
PMID: 39612152